Lumida
/ARGX
⌘K
argenx SE

argenx SE

ARGX
$1,023.21USD-3.37%-35.69 today

MARKET CAP

49.9B

P/E (TTM)

FWD P/E

DAY RANGE

$1,019 – $1,053

52W RANGE

$662
$1,062

AI Summary

Stalk
StalkMedium

ARGX has surged in a Stage 2 advance with parabola acceleration, but extreme overbought conditions and significant extension above the rising EMAs suggest near-term consolidation. Pullbacks into the 9-, 20-, and 50-day EMAs or the breakout support zone around $1,000–$964 offer structurally appropriate entry points.

  • Q2’26 VivGuard net sales $1.5B, +60% YoY adoption in MG/CIDP
  • PDUFA May 10, 2026 for seronegative MG could expand addressable market by ~11K patients
  • Q2’26 operating expenses hit $1B, pressuring profit margins
Full analysis →
Insider Trades0 trades
No trades match the current filters